Your institution may have access to this item. Find your institution then sign in to continue.
Title
Immunotherapy for drug-refractory mucosal leishmaniasis.
Authors
Badaro, Roberto; Lobo, Iza; Munos, Alvaro; Netto, Eduardo M; Modabber, Farrokh; Campos-Neto, Antonio; Coler, Rhea N; Reed, Steven G
Abstract
Pentavalent antimony (Sb(v)) is the mainstay therapy for mucosal leishmaniasis (ML), but it is toxic, and relapses are common. Immunotherapy using a mixture of killed parasites, with or without bacille Calmette-Guerin, is an alternative but is used sporadically because of inconsistent results.
Publication
The Journal of infectious diseases, 2006, Vol 194, Issue 8, p1151